# First Capital Inc: financial statements, quarterly

FCAP · Nasdaq · CIK 1070296 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fcap.md) · [Financials](/companies/fcap/financials.md) · [Filings](/companies/fcap/filings.md) · [Insiders](/companies/fcap/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/fcap/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [1,766](/filings/0001171843-24-006378.md) | [1,780 d](/filings/0001104659-26-037802.md) | [1,701](/filings/0001171843-25-003186.md) | [1,759](/filings/0001558370-25-011580.md) | [1,808](/filings/0001104659-25-112606.md) | [1,791 d](/filings/0001104659-26-037802.md) | [1,677](/filings/0001104659-26-059444.md) | [1,781](/filings/0001104659-26-094929.md) | [1,861](/filings/0001104659-25-112606.md) | [1,851 d](/filings/0001104659-26-037802.md) | [1,722](/filings/0001104659-26-059444.md) | [1,863](/filings/0001104659-26-094929.md) |
| Operating income | $k | [3,713](/filings/0001171843-24-006378.md) | [3,591](/filings/0001171843-24-001722.md) | [3,462](/filings/0001171843-25-003186.md) | [3,320](/filings/0001558370-25-011580.md) | [3,438](/filings/0001104659-25-112606.md) | [3,949 d](/filings/0001171843-25-001868.md) | [3,910](/filings/0001171843-25-003186.md) | [4,630](/filings/0001558370-25-011580.md) | [5,548](/filings/0001104659-25-112606.md) | not reported | not reported | not reported |
| Interest expense | $k | [2,642](/filings/0001171843-24-001722.md) | [3,091](/filings/0001171843-24-001722.md) | [3,237](/filings/0001171843-24-002868.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $k | [572](/filings/0001171843-24-006378.md) | [478](/filings/0001171843-24-001722.md) | [507](/filings/0001171843-25-003186.md) | [488](/filings/0001558370-25-011580.md) | [537](/filings/0001104659-25-112606.md) | [684 d](/filings/0001104659-26-037802.md) | [672](/filings/0001104659-26-059444.md) | [852](/filings/0001104659-26-094929.md) | [1,067](/filings/0001104659-25-112606.md) | [938 d](/filings/0001104659-26-037802.md) | [1,030](/filings/0001104659-26-059444.md) | [1,249](/filings/0001104659-26-094929.md) |
| Net income | $k | [3,138](/filings/0001171843-25-001868.md) | [3,110](/filings/0001171843-25-001868.md) | [2,952](/filings/0001104659-26-037802.md) | [2,828](/filings/0001104659-26-037802.md) | [2,898](/filings/0001104659-26-037802.md) | [3,262](/filings/0001104659-26-037802.md) | [3,235](/filings/0001104659-26-059444.md) | [3,775](/filings/0001104659-26-094929.md) | [4,478](/filings/0001104659-26-037802.md) | [4,879](/filings/0001104659-26-037802.md) | [4,330](/filings/0001104659-26-059444.md) | [4,762](/filings/0001104659-26-094929.md) |
| Diluted EPS | $ per share | [0.94](/filings/0001171843-25-001868.md) | [0.93](/filings/0001171843-25-001868.md) | [0.88](/filings/0001104659-26-037802.md) | [0.85](/filings/0001104659-26-037802.md) | [0.87](/filings/0001104659-26-037802.md) | [0.97](/filings/0001104659-26-037802.md) | [0.97](/filings/0001104659-26-059444.md) | [1.13](/filings/0001104659-26-094929.md) | [1.34](/filings/0001104659-26-037802.md) | [1.46](/filings/0001104659-26-037802.md) | [1.30](/filings/0001104659-26-059444.md) | [1.43](/filings/0001104659-26-094929.md) |
| Basic EPS | $ per share | [0.94](/filings/0001171843-25-001868.md) | [0.93](/filings/0001171843-25-001868.md) | [0.88](/filings/0001104659-26-037802.md) | [0.85](/filings/0001104659-26-037802.md) | [0.87](/filings/0001104659-26-037802.md) | [0.97](/filings/0001104659-26-037802.md) | [0.97](/filings/0001104659-26-059444.md) | [1.13](/filings/0001104659-26-094929.md) | [1.34](/filings/0001104659-26-037802.md) | [1.46](/filings/0001104659-26-037802.md) | [1.30](/filings/0001104659-26-059444.md) | [1.43](/filings/0001104659-26-094929.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Total assets | $m | [1,143](/filings/0001171843-23-007104.md) | [1,158](/filings/0001171843-25-001868.md) | [1,157](/filings/0001171843-24-002868.md) | [1,164](/filings/0001171843-24-004793.md) | [1,189](/filings/0001171843-24-006378.md) | [1,188](/filings/0001104659-26-037802.md) | [1,215](/filings/0001171843-25-003186.md) | [1,243](/filings/0001558370-25-011580.md) | [1,235](/filings/0001104659-25-112606.md) | [1,272](/filings/0001104659-26-094929.md) | [1,284](/filings/0001104659-26-059444.md) | [1,290](/filings/0001104659-26-094929.md) |
| Total liabilities | $m | [1,053](/filings/0001171843-23-007104.md) | [1,053](/filings/0001171843-25-001868.md) | [1,051](/filings/0001171843-24-002868.md) | [1,056](/filings/0001171843-24-004793.md) | [1,072](/filings/0001171843-24-006378.md) | [1,073](/filings/0001104659-26-037802.md) | [1,094](/filings/0001171843-25-003186.md) | [1,119](/filings/0001558370-25-011580.md) | [1,103](/filings/0001104659-25-112606.md) | [1,134](/filings/0001104659-26-094929.md) | [1,146](/filings/0001104659-26-059444.md) | [1,147](/filings/0001104659-26-094929.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001104659-26-037802.md) | not reported | [0.0](/filings/0001558370-25-011580.md) | [0.0](/filings/0001104659-25-112606.md) | [0.0](/filings/0001104659-26-094929.md) | [0.0](/filings/0001104659-26-059444.md) | [0.0](/filings/0001104659-26-094929.md) |
| Shareholders' equity | $m | [89.2](/filings/0001171843-23-007104.md) | [105](/filings/0001171843-25-001868.md) | [106](/filings/0001171843-24-002868.md) | [108](/filings/0001171843-24-004793.md) | [117](/filings/0001171843-24-006378.md) | [115](/filings/0001104659-26-037802.md) | [120](/filings/0001171843-25-003186.md) | [123](/filings/0001558370-25-011580.md) | [132](/filings/0001104659-25-112606.md) | [138](/filings/0001104659-26-094929.md) | [138](/filings/0001104659-26-059444.md) | [143](/filings/0001104659-26-094929.md) |

- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [5,543 d](/filings/0001171843-24-006378.md) | [957 d](/filings/0001104659-26-037802.md) | [7,219](/filings/0001171843-25-003186.md) | [3,482 d](/filings/0001558370-25-011580.md) | [7,580 d](/filings/0001104659-25-112606.md) | [4,064 d](/filings/0001104659-26-037802.md) | [4,387](/filings/0001104659-26-059444.md) | [3,724 d](/filings/0001104659-26-094929.md) | [7,941 d](/filings/0001104659-25-112606.md) | [5,232 d](/filings/0001104659-26-037802.md) | [6,341](/filings/0001104659-26-059444.md) | [4,251 d](/filings/0001104659-26-094929.md) |
| Capital expenditure | $k | [150 d](/filings/0001171843-24-006378.md) | [185 d](/filings/0001104659-26-037802.md) | [159](/filings/0001171843-25-003186.md) | [152 d](/filings/0001558370-25-011580.md) | [83.0 d](/filings/0001104659-25-112606.md) | [323 d](/filings/0001104659-26-037802.md) | [220](/filings/0001104659-26-059444.md) | [269 d](/filings/0001104659-26-094929.md) | [165 d](/filings/0001104659-25-112606.md) | [698 d](/filings/0001104659-26-037802.md) | [489](/filings/0001104659-26-059444.md) | [704 d](/filings/0001104659-26-094929.md) |
| Dividends paid | $k | [905 d](/filings/0001171843-24-006378.md) | [903 d](/filings/0001104659-26-037802.md) | [905](/filings/0001171843-25-003186.md) | [919 d](/filings/0001558370-25-011580.md) | [972 d](/filings/0001104659-25-112606.md) | [972 d](/filings/0001104659-26-037802.md) | [974](/filings/0001104659-26-059444.md) | [985 d](/filings/0001104659-26-094929.md) | [1,039 d](/filings/0001104659-25-112606.md) | [1,037 d](/filings/0001104659-26-037802.md) | [1,038](/filings/0001104659-26-059444.md) | [1,049 d](/filings/0001104659-26-094929.md) |
| Share repurchases | $k | [0.0 d](/filings/0001171843-24-006378.md) | [0.0 d](/filings/0001104659-26-037802.md) | [0.0](/filings/0001171843-25-003186.md) | [13.0 d](/filings/0001558370-25-011580.md) | [28.0 d](/filings/0001104659-25-112606.md) | [0.0 d](/filings/0001104659-26-037802.md) | [9.0](/filings/0001104659-26-059444.md) | [0.0 d](/filings/0001104659-26-094929.md) | [52.0 d](/filings/0001104659-25-112606.md) | [517 d](/filings/0001104659-26-037802.md) | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [3.4](/filings/0001171843-23-007104.md) | [3.4](/filings/0001171843-24-002868.md) | [3.3](/filings/0001171843-24-004793.md) | [3.3](/filings/0001171843-24-006378.md) | [3.3](/filings/0001171843-25-003186.md) | [3,345](/filings/0001558370-25-011580.md) | [3,347](/filings/0001104659-25-112606.md) | [3,348](/filings/0001104659-26-059444.md) | [3.4](/filings/0001104659-26-094929.md) | [3,350](/filings/0001104659-25-112606.md) | [3,339](/filings/0001104659-26-059444.md) | [3.3](/filings/0001104659-26-094929.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 3,344,625 at 2026-07-31, from the cover of the [10-Q filed 2026-08-12](/filings/0001104659-26-094929.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:32 ET. No prices; not investment advice.